| Neuropsychological deficits in long-term frequent cannabis users L Messinis, A Kyprianidou, S Malefaki, P Papathanasopoulos Neurology 66 (5), 737-739, 2006 | 160 | 2006 |
| Normative data and discriminant validity of Rey's Verbal Learning Test for the Greek adult population L Messinis, I Tsakona, S Malefaki, P Papathanasopoulos Archives of Clinical Neuropsychology 22 (6), 739-752, 2007 | 129 | 2007 |
| From Broca and Wernicke to the neuromodulation era: insights of brain language networks for neurorehabilitation G Nasios, E Dardiotis, L Messinis Behavioural neurology 2019, 2019 | 78 | 2019 |
| Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery A Papathanasiou, L Messinis, VL Georgiou, P Papathanasopoulos International Scholarly Research Notices 2014, 2014 | 78 | 2014 |
| Beneficial effect of multidomain cognitive training on the neuropsychological performance of patients with early-stage Alzheimer’s disease A Nousia, V Siokas, E Aretouli, L Messinis, AM Aloizou, M Martzoukou, ... Neural plasticity 2018, 2018 | 76 | 2018 |
| Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey P Papathanasopoulos, E Gourzoulidou, L Messinis, V Georgiou, ... Neuroepidemiology 30 (3), 167-173, 2008 | 75 | 2008 |
| Assessment and rehabilitation of cognitive impairment in multiple sclerosis L Messinis, MH Kosmidis, E Lyros, P Papathanasopoulos International Review of Psychiatry 22 (1), 22-34, 2010 | 73 | 2010 |
| Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status A Papathanasiou, L Messinis, P Zampakis, G Panagiotakis, P Gourzis, ... Journal of the neurological sciences 358 (1-2), 236-242, 2015 | 62 | 2015 |
| Neuropsychological function in Greek patients with chronic hepatitis C K Karaivazoglou, K Assimakopoulos, K Thomopoulos, G Theocharis, ... Liver International 27 (6), 798-805, 2007 | 61 | 2007 |
| Psychotic features associated with multiple sclerosis MH Kosmidis, M Giannakou, L Messinis, P Papathanasopoulos International Review of Psychiatry 22 (1), 55-66, 2010 | 57 | 2010 |
| Efficacy of a computer-assisted cognitive rehabilitation intervention in relapsing-remitting multiple sclerosis patients: a multicenter randomized controlled trial L Messinis, G Nasios, MH Kosmidis, P Zampakis, S Malefaki, K Ntoskou, ... Behavioural neurology 2017, 2017 | 56 | 2017 |
| Quality of life in multiple sclerosis: effects of current treatment options O Kargiotis, A Paschali, L Messinis, P Papathanasopoulos International review of psychiatry 22 (1), 67-82, 2010 | 55 | 2010 |
| Color Trails Test: Normative data and criterion validity for the Greek adult population L Messinis, AC Malegiannaki, T Christodoulou, V Panagiotopoulos, ... Archives of Clinical Neuropsychology 26 (4), 322-330, 2011 | 53 | 2011 |
| Efficacy of computer-based cognitive training in neuropsychological performance of patients with multiple sclerosis: A systematic review and meta-analysis E Dardiotis, A Nousia, V Siokas, Z Tsouris, A Andravizou, AFA Mentis, ... Multiple sclerosis and related disorders 20, 58-66, 2018 | 52 | 2018 |
| Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia? E Lyros, L Messinis, P Papathanasopoulos European journal of neurology 15 (3), 262-267, 2008 | 44 | 2008 |
| Cognitive and language deficits in multiple sclerosis: comparison of relapsing remitting and secondary progressive subtypes K Ntoskou, L Messinis, G Nasios, M Martzoukou, G Makris, ... The open neurology journal 12, 19, 2018 | 43 | 2018 |
| Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy L Messinis, E Lyros, V Andrian, P Katsakiori, G Panagis, V Georgiou, ... Human Psychopharmacology: Clinical and Experimental 24 (7), 524-531, 2009 | 40 | 2009 |
| Benton Visual Retention Test performance in normal adults and acute stroke patients: Demographic considerations, discriminant validity, and test–retest reliability L Messinis, E Lyros, V Georgiou, P Papathanasopoulos The Clinical Neuropsychologist 23 (6), 962-977, 2009 | 40 | 2009 |
| Corpus callosum atrophy as a marker of clinically meaningful cognitive decline in secondary progressive multiple sclerosis. Impact on employment status A Papathanasiou, L Messinis, P Zampakis, P Papathanasopoulos Journal of Clinical Neuroscience 43, 170-175, 2017 | 38 | 2017 |
| Cognitive impairment and brain reorganization in MS: underlying mechanisms and the role of neurorehabilitation G Nasios, C Bakirtzis, L Messinis Frontiers in neurology 11, 147, 2020 | 37 | 2020 |
